Scale -


  • Ebitda is 679 Rs Cr; Annual Growth is 27 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 22 %
  • PBT is 41.88 Rs Cr; Annual Growth is 50 %; 5 Year CAGR is 24 %
  • PAT is 220 Rs Cr; Annual Growth is 46 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 23 %
  • Revenue is 6892 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 16 %
  • Quarterly Revenue is 1880 Rs Cr; Continuous Growth over 3 Quarters

Profitability -


  • PBDIT Margin is 9.84 %; Annual Growth is 13 %; Continuous Growth over 3 years
  • PAT Margin is 3.18 %; Annual Growth is 30 %; Continuous Growth over 3 years
  • Quarterly Profit margin is 2 %; in Bottom Quartile

Return -


  • ROA is 5.58 %; Annual Growth is 25 %; Continuous Growth over 3 years
  • ROE is 11.11 %; Annual Growth is 29 %; Continuous Growth over 3 years
  • ROCE is 12.2 %; Continuous Growth over 3 years
  • Asset Turnover is 189 %; 5 Year CAGR is 104 %; Continuous Decline over 3 years

Efficiency -


  • Quick Ratio is 1; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 5.06; Continuous Growth over 3 years; 5 Year CAGR is 217 %
  • Operating cash flow is 496 Rs Cr; in Top Quartile; 5 Year CAGR is 31 %

Solvancy -


  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 21.67 Rs Cr; Annual Growth is 48 %

Quality -


  • Change in Inventories/Total Expenses is -1 %; Annual Decline is -580 %
  • Operating cashflow/ebitda is 73 %; Annual Decline is -28 %
  • Operating cashflow/PAT is 226 %; Annual Decline is -37 %
  • Other Expenses/Total Expenses is 5 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
MedPlus Health Services board to meet Nov 6 to consider share buy-back
MedPlus Health Services Limited (MEDPLUS.NS) Seasonal Returns Chart
MedPlus Health Services Limited (NSE:MEDPLUS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Catalyst Trusteeship pledges 34 lakh Medplus shares, holding hits 20%
Medplus Health Services Q2 Results FY27: PAT Rises 1.03% to Rs 56.07 Cr
India's MedPlus Health posts higher Q2 profit as retail revenue rises
MedPlus Health Posts Q2 Revenue of ?2,037 Crore vs ?1,679 Crore YoY
Medplus Health Services And 2 Other IPOs Coming This Week
How MedPlus Health Services Ltd (NSE: MEDPLUS) shares sit near a one-year low after a weak quarter
Medplus Health Services (MEDPLUS.NS) Slips 0.81% to ?607.0 as Stock Holds Mid-Range
Exploring perspectives on business transformation, innovation and global opportunities. Watch the exclusive interviews of Madhukar Gangadi Reddy, Founder & CEO, MedPlus and K. Ravi, Vice Chairman & MD, NCL Industries Limited from the Architects of Vi
MedPlus Health Services Ltd (NSE:MEDPLUS): Q1 FY27 Results and Pharmacy Expansion
What Are Biologics Maker, Specialty Ingredient and Pharmacy Retail Stocks?
MedPlus Health Services Pharmacy Expansion and Digital Healthcare Strategy
MedPlus Q1 FY27: Sales Up 21.8%, Profit Down 21.7%, Stock at Low
MedPlus Health Services (NSE: MEDPLUS) Q1 FY27 Revenue Rises 21.8%
Medplus promoter Agilemed pledges 5.5 lakh shares to maintain security cover
MedPlus Health Services (NSE: MEDPLUS): Stores Up, Profit Down
CareEdge Ratings Reaffirms Credit Ratings for MedPlus Subsidiary Optival Health Solutions